Please login to the form below

Not currently logged in
Email:
Password:

Drug prices

This page shows the latest Drug prices news and features for those working in and with pharma, biotech and healthcare.

US politicians round on generics firms for blocking drug pricing probe

US politicians round on generics firms for blocking drug pricing probe

Renews focus on increases in generic drug prices. US politicians are going after Heritage Pharmaceuticals, Mylan and Teva Pharmaceutical Industries for allegedly stonewalling an earlier effort to gather drug pricing information. ... That’s when Elijah

Latest news

  • White House unveils plans to reimport medicines from Canada White House unveils plans to reimport medicines from Canada

    The plans are an escalation in the president’s on-off assault on drug prices, which he and his Republican party, and the opposition Democrat party, are focusing on as a ... tackle high drug prices.

  • PhRMA opposed to Senate drug price control plans PhRMA opposed to Senate drug price control plans

    But has bipartisan support and Trump backing. Long-awaited Senate Finance Committee proposals to tackle high drug prices through Medicare and Medicaid have been slammed by the trade organisation representing pharma ... Republican Senator Chuck Grassley

  • Another setback on pricing as Trump drops rebate plans Another setback on pricing as Trump drops rebate plans

    It’s the second defeat for the President this week, coming after the drug industry successfully blocked an HHS plan to require television ads for medicines to publish list prices if ... spokesman. “President Trump will consider using any and all

  • Trump presses on with reference pricing plan for medicines Trump presses on with reference pricing plan for medicines

    Setting US prices against those overseas is just the latest in a series of new proposals in Trump’s war on drug prices, coming after plans to do away with the ... In a preamble to the latest executive order announcement, Trump also claimed – wrongly

  • Europe urged to adapt faster to gene therapy challenges Europe urged to adapt faster to gene therapy challenges

    on drug prices in Germany, Ulf Persson, health economist in Sweden, Pilar Pinilla-Dominguez, NICE’s ATMP expert in the UK and Mira Pavlovic, HAS/EMA adviser, early dialogue expert in ... Novartis' $2.12m SMA gene therapy Zolgensma - now the world's

More from news
Approximately 23 fully matching, plus 166 partially matching documents found.

Latest Intelligence

  • The fight for affordable insulin The fight for affordable insulin

    In April, in response to growing outrage over the problem (and the wider issue of rising drug prices), executives from pharma companies, pharmacy benefit managers (PBMs) and health insurers were hauled ... Recent weeks have seen President Trump shift his

  • The Cystic Fibrosis Buyers’ Club The Cystic Fibrosis Buyers’ Club

    At the same time, Just Treatment is part of a growing movement that is seeking greater data sharing between governments on drug prices, in order to give individual nations more leverage ... Meticulous preparations. The supply of the generic drug comes

  • The rise of CEO activism The rise of CEO activism

    Frazier took to Twitter to make his stand and, within an hour, Trump responded by calling for Mr Frazier to spend his new-found free time “lowering rip-off drug prices”.

  • The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt

    There is no conceivable scenario in which any government would accept the political risk of reducing the threshold: every patient denied access to a drug as a result would be a ... I do not believe the government wants to be trapped in a situation where

  • The Orkambi blame game The Orkambi blame game

    Grilling by MPs sheds some light on long-running row over CF drug. ... The three-hour evidence session also bore some resemblance to the recent interrogation of seven big pharma CEOs by a US Senate committee enquiry into US drug prices, albeit with just

More from intelligence
Approximately 2 fully matching, plus 27 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Oncology drugs under AMNOG

    Part 1: Segmentation and comparator choice - lessons for cancer drug market access in Germany. ... How to prepare. Germany is one of the largest pharmaceutical markets in Europe and drug prices there are used as reference prices in other markets.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics